Ultrasound Imaging Agent Launched in India

July 16, 2010 – Lantheus Medical Imaging Inc. this week announced the launch of its ultrasound contrast imaging agent, Definity Vial For (Perflutren Lipid Microsphere) Injectable Suspension, in India.

The company has signed a multiyear agreement with Mumbai-based J.B. Chemicals & Pharmaceuticals Ltd. (JBCPL) for the distribution and marketing of Definity in the Indian marketplace. The launch expands Lantheus’ presence in southern Asia. Definity is currently marketed in North America, Australia and New Zealand, parts of the Pacific Rim, and several countries in the Middle East.

Definity is an ultrasound contrast imaging agent that is indicated in India for use in patients with suboptimal echocardiograms to opacify the left ventricular chamber and to improve the delineation of the left ventricular endocardial border, as well as for use in patients in contrast-enhanced diagnostic ultrasound imaging to improve characterization of focal lesions of the liver and kidney.

Related Content

Hologic, Inc. announced he U.S. launch of the SuperSonic MACH 40 ultrasound system, expanding the company’s suite of ultrasound technologies with its first premium, cart-based system.

News | Breast Imaging | July 08, 2020

Hologic Launches Cart-based Ultrasound System

July 8, 2020 — Hologic, Inc. announced he U.S.

Fujifilm’s Sonosite SII POC ultrasound system helps to keep crowded areas clearer with a small ultrasound footprint.

Fujifilm’s Sonosite SII POC ultrasound system helps to keep crowded areas clearer with a small ultrasound footprint.

Feature | Ultrasound Imaging | July 07, 2020 | By Joan Toth

Utility of Point-of-Care Ultrasound Across Clinical Applications Spurs Continued Growth

With the miniaturization of technology, improved ease of use, lower system cost, increased portability and greater ac

Hoya Corp. and Hitachi, Ltd. announced a five year contract regarding Endoscopic Ultrasound Systems [EUS] by which the parties will strengthen technical collaboration, and Hitachi will continue supplying diagnostic ultrasound systems and ultrasound sensor related parts used in EUS.

News | Ultrasound Imaging | July 06, 2020

Hoya and Hitachi Announce Collaboration and Supply Agreement Related to Endoscopic Ultrasound Systems

July 6, 2020 — Hoya Corp. and Hitachi, Ltd.

Industry leaders to research the growing importance of point-of-care ultrasound in COVID-19 care

News | Coronavirus (COVID-19) | July 02, 2020

Fujifilm Sonosite and EMF Partner in the Battle Against COVID-19

July 2, 2020 —...

A 3-D ultrasound system provides an effective, noninvasive way to estimate blood flow that retains its accuracy across different equipment, operators and facilities, according to a study published in the journal Radiology.

Volume flow as a function of color flow gain (at a single testing site). For each row the color flow c-plane and the computed volume flow are shown as a function of color flow gain. The c-plane is shown for four representative gain levels, whereas the computed volume flow is shown for 12–17 steps across the available gain settings. Flow was computed with (solid circles on the graphs) and without (hollow circles on the graphs) partial volume correction. Partial volume correction accounts for pixels that are only partially inside the lumen. Therefore, high gain (ie, blooming) does not result in overestimation of flow. Systems 1 and 2 converge to true flow after the lumen is filled with color pixel. System 3 is nearly constant regarding gain and underestimates the flow by approximately 17%. Shown are mean flow estimated from 20 volumes, and the error bars show standard deviation. Image courtesy of the journal Radiology

News | Ultrasound Imaging | July 01, 2020

3-D Ultrasound Enables Accurate, Noninvasive Measurements of Blood Flow

July 1, 2020 — A 3-D ultrasound